UBR5 Antikörper (Ubiquitin Protein Ligase E3 Component N-Recognin 5) (Cy5)

Details for Product anti-UBR5 Antibody No. ABIN1704212
Antigen
  • DD5
  • EDD
  • EDD1
  • HYD
  • 4432411E13Rik
  • AW549941
  • C77315
  • D030042K14
  • Edd
  • Edd1
  • mKIAA0896
  • Dd5
  • Rat100
  • ubiquitin protein ligase E3 component n-recognin 5
  • UBR5
  • Ubr5
Reaktivität
Human, Maus, Ratte (Rattus)
92
53
25
11
9
6
5
4
4
4
2
1
1
1
1
Wirt
Kaninchen
69
21
3
1
Klonalität
Polyklonal
Konjugat
Dieser UBR5 Antikörper ist konjugiert mit Cy5
5
4
4
3
3
3
2
2
2
2
2
1
1
1
1
1
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
52
47
47
21
12
6
3
3
1
Optionen
Immunogen KLH conjugated synthetic peptide derived from human EDD
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere UBR5 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung Ubr5 (UBR5 Antibody Abstract)
Hintergrund

EDD is a progestin-regulated gene that was isolated from T-47D human breast cancer cells. Based on sequence homology, EDD appears to be a human homolog of the Drosophila hyperplastic discs (hyd) gene, a tumor suppressor gene that is required for control of imaginal disc growth. EDD contains a HECT domain in the carboxy terminus. HECT domain-containing proteins function as ubiquitin-protein ligases, or E3 enzymes. EDD has been shown to bind to ubiquitin, and like other HECT family proteins, may function as an E3 ubiquitin-protein ligase.

Synonyms: 4432411E13Rik, AW549941, C77315, D030042K14, DD5, E3 identied by dferential display, E3 ubiquitin protein ligase, HECT domain containing, 1, E3 ubiquitin-protein ligase, E3 ubiquitin-protein ligase UBR5, EDD 1, EDD, EDD, EDD1, FLJ11310, HECT domain-containing 1, hHYD, HYD, Hyperplastic discs protein homolog, KIAA0896, MGC57263, mKIAA0896, Progestin induced protein, Progestin-induced protein, Rat100, Ubiquitin protein ligase, Ubiquitin protein ligase E3 component n recognin 5, UBR5, UBR5_HUMAN.

Gen-ID 51366
Pathways Intracellular Steroid Hormone Receptor Signaling Pathway
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?